NewGenIvf (NASDAQ: NIVF) implements 1-for-3 reverse stock split in July 2026
Rhea-AI Filing Summary
NewGenIvf Group Limited is implementing a reverse stock split of all issued and unissued share classes at a ratio of one new share for every three existing shares. This is being carried out by the Board under the BVI Business Companies Act and the company’s M&A without a shareholder vote.
The reverse split will be effective at 12:01 a.m. (ET) on July 6, 2026, and the Class A ordinary shares will begin trading on Nasdaq on a split-adjusted basis that same day under the symbol NIVF with a new CUSIP G0544E501. The number of outstanding Class A ordinary shares will change from 10,259,764 to approximately 3,419,922.
Every three existing Class A ordinary shares will automatically combine into one new share, with no fractional shares issued; holders who would otherwise receive a fraction will instead receive one full post-split share at the participant level. All options, warrants and other convertible securities will be adjusted by dividing the underlying share amounts by three, rounded to the nearest whole share, while par value remains nil and the company’s unlimited authorized share capital is unchanged.
Positive
- None.
Negative
- None.
Insights
NewGenIvf executes a 1-for-3 reverse split, consolidating shares without changing total equity value.
The company is consolidating every three existing shares into one, cutting outstanding Class A ordinary shares from 10,259,764 to about 3,419,922. Reverse splits typically leave overall market capitalization unchanged but can lift the per-share trading price by the same ratio.
All options, warrants and other convertible securities are being proportionally adjusted, preserving holders’ economic exposure. No shareholder approval was required under the BVI framework, and authorized capital remains unlimited, so the move mostly restructures the share count rather than altering the underlying capital structure.